ICH Q3E Guideline:​Extractables & Leachables

ICH Q3E Guideline is changing how the pharmaceutical industry approaches Extractables & Leachables (E&L) — especially for complex formulations, biologics, peptides, and long-acting injectables. In this video, we break down what ICH Q3E really means, why it matters for ANDA and IND submissions, and how extractables and leachables from packaging, delivery systems, and manufacturing components can impact drug safety, stability, and regulatory approval. Many pharmaceutical programs fail or face delays not because of API issues — but due to unknown leachables migrating from container closure systems, elastomers, syringes, tubing, or polymeric materials. This makes early E&L assessment critical for regulatory success. Understanding ICH Q3E early can prevent regulatory questions, stability failures, and costly rework during late-stage development. If you're working on drug product development, packaging qualification, or regulatory submissions — this is a must-know guideline. #ICHQ3E #ExtractablesAndLeachables #PharmaceuticalRND #ICHGuidelines #Leachables #Extractables #DrugDevelopment #PharmaRegulatory #CMC #ANDA #IND #PharmaPackaging #AnalyticalChemistry #LCMS #GCMS #ICPMS #BiologicsDevelopment #PeptideDrugs #ComplexGenerics #PharmaIndustry #RegulatoryScience #ContainerClosure #PharmaQuality #DrugProductDevelopment